| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Kroeger Christopher A. | Chief Executive Officer, Director | C/O MAPLIGHT THERAPEUTICS, INC., 800 CHESAPEAKE DRIVE, REDWOOD CITY | /s/ Kristopher L. Hanson, Attorney-in-Fact | 09 Feb 2026 | 0001658918 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | MPLT | Voting Common Stock | Award | $0 | +23,145 | +1.4% | $0.000000 | 1,649,751 | 05 Feb 2026 | Direct | F1, F2 |
| holding | MPLT | Voting Common Stock | 101,190 | 05 Feb 2026 | See footnote | F3 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | MPLT | Employee Stock Option (right to buy) | Award | $0 | +93,955 | $0.000000 | 93,955 | 05 Feb 2026 | Voting Common Stock | 93,955 | $15.70 | Direct | F4 |
| Id | Content |
|---|---|
| F1 | Represents a restricted stock unit ("RSU") award. 1/4th of the RSUs shall vest on January 1, 2027, and 1/16th of the RSUs shall vest on each subsequent April 1, July 1, October 1 and January 1 thereafter, subject to the Reporting Person's continued service through each vesting date. |
| F2 | Each RSU represents a contingent right to receive one share of voting common stock of the Issuer. |
| F3 | The shares are held by the C&M Kroeger Nominee Trust, of which the Reporting Person is co-trustee with his spouse and has voting and dispositive power. |
| F4 | 1/4th of the total shares underlying the option shall vest on February 5, 2027, and 1/48th of the total shares shall vest each month thereafter on the same day of the month, subject to the Reporting Person's continued service through each vesting date. |